Navigation Links
Pharmasset Reports Fiscal First Quarter 2009 Financial Results
Date:2/9/2009

bination of two oral antiviral molecules to treat hepatitis C virus (HCV) in the absence of interferon. The study will investigate the combination of Pharmasset's R7128 with InterMune's R7227, a protease inhibitor;

-- On January 11, 2009, Pharmasset announced that the company and its development partner, Roche, had agreed with the FDA on the design for a phase 2b trial with R7128, a nucleoside inhibitor of HCV, slated to initiate in the first calendar quarter of 2009;

-- On January 30, 2009, Pharmasset filed an IND for PSI-7851, a nucleotide inhibitor of HCV, with the FDA and expects to initiate a Phase 1 clinical trial to study safety and pharmacokinetics in healthy volunteers at the end of the first calendar quarter of 2009;

-- On January 30, 2009, Pharmasset and Bukwang Pharm. Co., Ltd. entered into an amendment of their license agreement covering clevudine. The amendment expands the territories in which Pharmasset has been granted rights to include Australia, Japan, New Zealand and Taiwan;

-- On February 5, 2009, Pharmasset completed a registered direct offering that raised net proceeds of $43.5 million.

"We had a very productive start to 2009, filing an IND for PSI-7851, our second generation nucleotide for HCV and, strengthening our balance sheet by raising $43.5 million in a tough financial market" stated Schaefer Price, President and Chief Executive Officer. "Our goal remains to build a leading franchise of nucleoside inhibitors for hepatitis C and B. Our plan is to provide updates throughout the year on all of our programs, including the first antiviral data on PSI-7851 in the second half of 2009."

Calendar Year 2009 Anticipated Milestones:

-- Roche initiates phase 2b study of R7128 in first quarter of 2009;

-- Complete enrollment of clevudine registration trials at end of first quarter of 2009;

-- Initiate
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
2. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
3. Pharmasset to Present at Two Upcoming Investor Conferences
4. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
5. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
6. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
7. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
8. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
9. Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
10. Pharmasset Joins Russell 3000 Index
11. Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...NGTON, Colo., Nov. 5 The endangere...n the western U.S. This rare carnivore feeds on p...le to plague and often entire population die-offs ...ice (FWS) has implemented a ferret breeding progra...into their formerly native habitat. Unfortunately...
(Date:11/5/2009)..., Neb., Nov. 5 Transgeno...ed financial results for the quarter ended Septemb...resented in the tables that follow. ,, Third Q... of $366,000 or $0.01 per share for the third quar...or $0.01 per share for the third quarter of 2008. ...
(Date:11/5/2009)...NT, Calif., Nov. 5 Wafer... leading developer of state-of-the-art genetic ana...ars, Ph.D. has joined the company,s Scientific Adv...ning and commercializing novel molecular diagnosti...d on the development of computational biology syst...
(Date:11/5/2009)... Brooke Sanders brings a new look to...PRWEB) November 5, 2009 -- Professional Reprograph...aphics company is pleased to present Brooke Sander...r graphics/PR specialist. The addition of Brooke t...growth within Professional Reprographics., , ,Broo...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
... top prize of $7,500 in seed capital are on the li...etition sponsored by BizFilings , a company headq...oundation . , ,The contest, named Plan for the Fut...gh-school students until May 31. They,ll be judged...Foundation: Contest guidelines , ,Contests like t...
...in the workplace. It pits incumbent powers against...ho covet the traditional employment deal money, c...al commitment to playing the organizational game b...e, grueling travel, and an otherwise unquestioning... Only Type A,s need apply. , ,On the other side is...
...its scientists have developed a way to make antibo...ally part of the immune system, are manufactured b...ics or research. Mirus, new technique, described i...travenously injecting DNA into animals, whose immu...ed and used. , ,According to the Madison-based bio...
Other Biology Technology:Who will win the battle to redefine the workplace? 2Who will win the battle to redefine the workplace? 3Who will win the battle to redefine the workplace? 4Who will win the battle to redefine the workplace? 5
(Date:11/4/2009)...alif., Oct. 19 Spectros, developer...d imaging devices which shed light on life-threate...exclusive distribution deals for both its T-Stat&#... covered include Australia, New Zealand, The Neth...Italy, France, Spain, Portugal, Poland, Greece, Tu...
(Date:11/4/2009)... Oct. 23 GenVault Corporation, the...t for genomic discovery, medicine and identificati...ault,s President and CEO, will be presenting at th...er 26th and 27th in La Jolla, CA. ,, During the... of the company together with recent customer, tec...
(Date:11/4/2009)...PRNewswire/ -- Glencoe Software, Inc., the commerc...onsortium ( http://openmicroscopy.org ), is prou...Society of Cell Biology,s exciting new project tit...n awarded a $2.5M stimulus grant through the Natio...es program, as part of the American Reinvestment a...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 1Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 2Greenberg Traurig Attorney Selected For Massachusetts Life Sciences Collaborative Task Force 55324 1Greenberg Traurig Attorney Selected For Massachusetts Life Sciences Collaborative Task Force 55324 2CareFusion Corp to be Included in S 26P 500 Index 55322 1CareFusion Corp to be Included in S 26P 500 Index 55322 2
...dy vines that University of WisconsinMilwaukee eco...pical forests of Panama, the largest has a stalk n... a large tree," says Schnitzer. "And because it wi... can cover as much canopy area as a community of t...heir energy on extending high and wide, and plungi...
...ry offer new possibilities for Insurance, Utilit... ROCHESTER, N.Y., Aug. 5 Pictometry International... image libraries whose,proprietary technology is u...day announced a powerful new alliance with First A...t American Corporation, which combines,Pictometry,...
... , By examining natural variation among cottonwo...al Laboratory hope to develop a strategy to maximi...Through a process known as association mapping, sc...ell wall chemistry among trees growing in natural ... trees are the best candidates for biofuel. To do ...
Other Biology News:Vine invasion? UWM ecologist looks at coexistence of trees and lianas 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 3Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM) 2Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM) 3Story tips from the US Department of Energy's Oak Ridge National Laboratory, August 2008 2Story tips from the US Department of Energy's Oak Ridge National Laboratory, August 2008 3
Rabbit Anti-Shh Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Anti-Human C5 / C5b Monoclonal Antibody, Unconjugated, Clone 568 from Cell Sciences
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Biology Products: